Yahoo Web Search

  1. Ad
    related to ELI LILLY AND COMPANY
  1. Importantly, patients who were treated with Tibsovo had a 6-month and 12-month PFS rate of 32% and 22%, respectively, while none of the patients in the placebo arm was free from ...

  2. PFE announced that its investigational oral JAK1 inhibitor abrocitinib has met all co-primary and key secondary endpoints in the second pivotal phase III study (B7451013). The double-blind ...

  3. Following the acquisition closure of GlaxoSmithKline's plant, Thermo Fisher (TMO) will continue to manufacture APIs for the same under a multi-year supply agreement.

  4. J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector

    Zacks via Yahoo FinanceOct 10 14:34 PM

    Johnson & Johnson JNJ will report third-quarter 2019 results on Oct 15, before market open. In the last reported quarter, the company delivered positive earnings surprise of 6.61%.

  5. NASDAQ: GILD) Type of Application: sNDA Candidate: Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets) Indication: Pre-exposure prophylaxis, or PrEP, for HIV-1 infection ...

  6. Hedge Funds Are Selling Royal Bank of Canada (RY)

    Insider Monkey via Yahoo FinanceOct 10 13:55 PM

    A pair of the less known formulas are hedge fund and insider trading activity.

  7. The phase III study is part of the phase III program, which includes two identical phase III studies to evaluate safety and efficacy of lebrikizumab as monotherapy in patients. The studies ...

  8. PREVENT is an ongoing two-year randomized, double-blind, placebo-controlled phase III study (with a two-year extension phase) investigating the efficacy and safety of Cosentyx in patients ...

  9. The FINCH phase III program evaluated the efficacy and safety of 100 mg and 200 mg filgotinib once daily in early-stage to biologic-experienced RA patients. FINCH 1 was a 52 week ...

  10. They were Bristol-Myers Squibb's (NYSE:BMY) $74 billion buyout of Celgene and AbbVie's (NYSE:ABBV) $63 billion acquisition of Allergan. "Life sciences CEOs realize that it makes sense ...

  1. Ads
    related to ELI LILLY AND COMPANY